New
Daisies
The AI engine Fit Assessment
BetaDaisies utilizes AI technology to improve diagnosis and provides comprehensive care for women's health, making it a suitable fit for the requirements.
Blurb
Daisies is a telemedicine platform that provides treatment for women’s health in a comprehensive manner.
HQ Location
Mexico
Founded
2021
Employees
11 - 50
Total funding raised
$50.00K
Last Funding Event
Pre-Seed, $50.00K, October 31, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Artificial Intelligence in Women's Health Care
Developer of a telemedicine platform intended to provide treatment for women's health in a comprehensive manner. The company's platform is an artificial intelligence (AI) powered pre-consultation protocol that improves diagnosis optimizes time and costs and offers its users nutrition, psychology, gynecology, and skincare consultations, all in one subscription, enabling users to save their money by buying only one subscription for health care.